Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Issues Recall on Eye Drops
FDA: Popular Eye Drops Recalled Over Fungal Contamination, Risk of Eye Infection
A batch of Systane Lubricant Eye Drops Ultra PF has been recalled after a customer complained of "foreign matter" in the drops—which turned out to be fungus.
Systane eye drops recalled due to fungal contamination: FDA
One lot of Systane Lubricant Eye Drops Ultra PF, manufactured by Alcon Laboratories, has been recalled due to fungal contamination, the FDA announced this week.
Major eye drops brand being recalled due to fungal contamination
Alcon Laboratories in Texas is voluntarily recalling a type of Systane lubricating eye drops that were distributed nationwide.
FDA Issues Recall on Eye Drops Due to Fungal Contamination
Alcon Laboratories has issued a recall of eye drops after discovering a fungal contamination in one of its products. The recall affects Systane Lubricant Eye Drops Ultra PF, and only a single lot of Systane drops are possibly contaminated.
Eye drops recalled nationwide for risk of ‘fungal contamination’ that can cause eye infections
The US Food and Drug Administration has recalled Systane Lubricant Eye Drops Ultra PF due to a risk of fungal contamination. The eye drops are typically used to cause temporary relief from dry eyes or irritation.
Recall: Systane eye drops may have possible 'fungal contamination' risk
The eye drops are typically used for temporary relief of burning and irritation for people with dry eye symptoms.
Eye drops sold at Publix, Amazon recalled for fungal contamination. What you should know
Systane Lubricant Eye Drops in a green and pink carton design, with “Systane” and “ULTRA PF” brand names on the front of the carton, and the “25 vials” package size marked Lot 10101 were recalled for possible fungal contamination on Dec. 20, 2024. The expiration date is stamped as 2025/09. Systane/Alcon Laboratories FDA
Systane eye drops recalled due to potential fungal contamination
Fungal contamination of an eye product is known to potentially cause eye infections, which may be vision- or life-threatening, according to the FDA.
FDA Announces Nationwide Eye Drops Recall Due to Fungal Contamination
"There have been no reports of adverse events related to this recall," Alcon Laboratories said in a statement about its Systane eye drops
Eye drops recalled nationwide due to fungal contamination
A brand of eye drops sold nationally has been recalled due to the presence of fungus, which may cause vision damage.
ophthalmologytimes
50m
Women advised to take part in Dry January to reduce dry eye risk
A study conducted on over 77,000 individuals found that alcohol consumption increased the risk of dry eye in women.
6d
Systane eye drops recalled for possible fungal contamination, FDA says
Systane brand eye drops were voluntarily recalled because of possible fungal contamination, the Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Russian drone strike on Kyiv
Broccoli recalled
Oldest Olympic champ dies
Winter storm warnings
Sugar Bowl postponed
Quake strikes Lake County
'General Hospital’ actor dies
Queens nightclub shooting
Pulls out of Glastonbury
Tesla Cybertruck explosion
New rules for next Congress
Homemade bombs in Va.
Montenegro mass shooting
Texas wins Peach Bowl
New NC gov. sworn in
How to watch Quadrantids
Israeli airstrikes in Gaza
China hacks sanctions office
Russian gas to Europe halted
New Orleans terror attack
Hawaii fireworks explosion
Puerto Rico power restored
Preinaugural rally in DC
Baldoni files $250M lawsuit
Pearl Harbor survivor dies
Faces new charges
Remains ID'd after 30+ yrs
Pentagon chief loses bid
PA voting machine ruling
Commutes death sentences
Cold case killer identified
Related topics
Systane
Alcon
Food and Drug Administration
Feedback